Developing new vaccines to protect against influenza and COVID-19
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center
This study is all about developing new vaccines and ways to deliver them to help protect you from different types of flu and COVID-19, and it will involve testing these vaccines to see how well they work in real life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11042032 on NIH RePORTER |
What this research studies
This research focuses on creating and testing innovative vaccine candidates and delivery methods to provide strong and lasting immunity against various strains of influenza and the COVID-19 virus. The approach includes detailed immunologic analyses to guide vaccine design, as well as laboratory testing to assess the effectiveness of these vaccines. Clinical studies will also be conducted to evaluate how well these vaccines work in real-world settings, aiming to improve public health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at higher risk for influenza and COVID-19, such as the elderly, healthcare workers, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or COVID-19, or those who have already been vaccinated and are not eligible for further vaccination, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that provide better protection against influenza and COVID-19.
How similar studies have performed: Previous research has shown promise in developing effective vaccines for influenza and COVID-19, indicating that this approach has potential for success.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Moody, Tony — Duke University
- Study coordinator: Moody, Tony
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.